跳至主要内容
临床试验/ACTRN12620001293954
ACTRN12620001293954尚未招募未知

Sonomat for detecting sleep apnoea in patients with interstitial lung disease (ILD): a novel screening tool in an at-risk population.

Sydney local health district0 个研究点目标入组 30 人开始时间: 2020年11月30日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Research participants will be recruited from a cohort of adult patients attending a tertiary specialist clinic with the diagnosis of fibrotic interstitial lung disease (ILD) (Royal Prince Alfred Hospital). Patients will be eligible for inclusion if they are 18 years of age or older, and have been diagnosed with ILD confirmed through multidisciplinary discussion, following international guidelines.

排除标准

  • Current CPAP or oxygen therapy use; known heart failure; bronchiectasis or chronic obstructive pulmonary disease; major psychiatric or neurological disorders; inability to provide informed consent or comply with the study requirements.

研究者

相似试验

Sonomat; A novel tool for evaluating sleep apnoea... | 临床试验